Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Cardiomyopathy_Paediatric

Gene: TSFM

Green List (high evidence)

TSFM (Ts translation elongation factor, mitochondrial, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000123297
EnsemblGeneIds (GRCh37): ENSG00000123297
OMIM: 604723, ClinGen, DECIPHER
TSFM is in 14 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Combined oxidative phosphorylation deficiency 3, MIM# 610505

Richard Lin (Victorian Clinical Genetics Services)

Green List (high evidence)

TSFM encodes for the mitochondrial translation elongation factor T (EFT). Biallelic pathogenic variants are definitively associated with autosomal recessive mitochondrial disease (ClinGen). Seven papers (PMID 31267352, PMID 27677415, PMID 31451716, PMID 30911037, PMID 35071363) report seven unrelated families (eight patients) with biallelic TSFM variants presenting with childhood‑onset hypertrophic cardiomyopathy (hypertrophic or dilated), lactic acidosis and neurologic involvement.

PMID: 17033963 - 1 female neonate diagnosed with severe concentric hypertrophic cardiomyopathy with a homozygous missense variant in TSFM:c.997C>T, (p.Arg312Trp)
PMID: 21741925 - 1 female neonate was found to have hypertrophic cardiomyopathy at birth, homozygous for TSFM:c.934C>T variant
PMID: 25037205 - 2 sibs, one family, both diagnosed with paediatric onset hypertrophic cardiomyopathy at 10 mo (P1) and 16 mo (P2) of age. Compound heterozygous for TSFM: c.[944G>A];[856C>T], p.[(Cys315Tyr)];[(Glu286*)].
PMID: 27677415 - male child diagnosed with hypertrophic cardiomyopathy at age 11, homozygous for c.719G>C missense variant. Abnormal biochemical defects identified in fibroblast cells, corrected with overexpression of wild type TSFM.
PMID: 31267352 - male infant with hypertrophic cardiomyopathy diagnosed at age 11 months, with a homozygous missense variant c.547G>A, p.(Gly183Ser)
PMID: 31451716 - 1 child with infantile onset LV hypertrophy, compound heterozygous for TSFM: c.[331_340del];[57G>A]
PMID: 35071363 - 3 year old female with hypertrophic cardiomyopathy, compound heterozygous variants in TSFM: c.[355G>C];[997C>T]
Created: 25 Aug 2026, 1:33 p.m. | Last Modified: 25 Aug 2026, 1:33 p.m.
Panel Version: 1.147

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Mitochondrial disease, MONDO:0044970

Publications

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
26 Aug 2026, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: tsfm has been classified as Green List (High Evidence).

26 Aug 2026, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: TSFM were changed from Required for mitochondrial gene expression (Mitochondrial respiratory chain disorders (caused by nuclear variants only)); Combined oxidative phosphorylation deficiency 3, 610505; Combined oxidative phosphorylation deficiency 3 610505 to Combined oxidative phosphorylation deficiency 3, MIM# 610505

26 Aug 2026, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: TSFM were set to 27604308

28 Jul 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: TSFM was added gene: TSFM was added to Cardiomyopathy_Paediatric. Sources: NHS GMS,South West GLH,Expert Review Green Mode of inheritance for gene: TSFM was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TSFM were set to 27604308 Phenotypes for gene: TSFM were set to Required for mitochondrial gene expression (Mitochondrial respiratory chain disorders (caused by nuclear variants only)); Combined oxidative phosphorylation deficiency 3, 610505; Combined oxidative phosphorylation deficiency 3 610505